Felzartamab Selectively and Potently Targets CD38+ Antibody-Secreting Cells from Patients with Immune-Mediated Kidney Diseases SA-PO721

Saved in:
Bibliographic Details
Published inJournal of the American Society of Nephrology Vol. 35; no. 10S
Main Authors Delfino, Tess Arenzana, Ilieva, Kristina M., Landgraf, Karin, Boxhammer, Rainer, Steidl, Stefan, Flesher, Donna
Format Journal Article
LanguageEnglish
Published 01.10.2024
Online AccessGet full text

Cover

More Information
ISSN:1046-6673
1533-3450
DOI:10.1681/ASN.2024s1kbcs27